Around 90% of individuals that meet clinical criteria for CS have an identifiable CHD7 variant. Before the identification of the molecular etiology of CS in 2004, individuals were diagnosed solely based on clinical characteristics. Data reporting cognitive, behavioural, and psychiatric features in CS warrant synthesis to definitively describe the behavioural phenotype in the condition.ĭiagnostic criteria have been revised several times to accommodate new insights (e.g. Psychiatric diagnoses in children and adults include anxiety, obsessive-compulsive disorder, attention deficit disorder, and autism. Moreover, sleep problems, anxiety, emotional dysregulation, aggression, self-injurious behaviour and tactile defensiveness are reported in adolescents and adults with CS. Consequently, ID is often based on informant measures of adaptive behaviour that might not correlate well with cognitive performance. Direct cognitive assessments are rarely appropriate as performance requires adequate communication and minimal sensory impairment. Developmental delay (DD) and intellectual disability (ID) have received the most attention and feature in all diagnostic algorithms (Table 1). While physical health in CS has been extensively documented research on development and behaviour is sparce. Identifying and understanding these impacts can help build resilience and early support strategies utilising multidisciplinary practices. These conditions will likely have a deleterious impact on emotional and psychological wellbeing. developed a comprehensive checklist for proactive monitoring of common or critical physical conditions and characteristics. ĬS is associated with many disparate physical conditions requiring health monitoring throughout life. However, given the rarity of CS and the spectrum of clinical findings, better delineation of genotype-phenotype associations requires pooling of data across data sets. Prospective investigation of genotype-phenotype correlations has been performed with an association between truncating CHD7 variants and more severe heart defects being identified. The prevailing hypothesis is that the dynamic role of CHD7 during gene expression and neural crest development may account for the pleiotropic signs and symptoms of CS. Mechanistically, CHD7 is essential for the differentiation of gene expression at thousands of sites in the human genome. Heterozygous variants in the chromodomain helicase DNA binding protein 7 (CHD7) cause CS. Our comprehensive review of clinical features, behavioural, psychological, cognitive and physical characteristics, conditions and comorbidities in CHARGE syndrome provides an empirically based foundation to further research and practice. Meta-regression indicated significant associations between intellectual disability and choanal atresia, intellectual disability and inner ear anomalies, sleep difficulties and growth deficiency, and sleep difficulties and gross motor difficulties. Prevalence estimates were highest for developmental delay (84%), intellectual disability (64%), aggressive behaviour (48%), self-injurious behaviour (44%) and sleep difficulties (45%). Of the 42 eligible studies, data could be extracted for 1675 participants. Pooled prevalence estimates were calculated using reliable, prespecified quality weighting criteria, and meta-regression was conducted to identify associations between characteristics. This meta-analysis investigated the prevalence of clinical features, physical characteristics and conditions, behavioural, psychological, cognitive and sleep characteristics in CHARGE syndrome, and statistically evaluated directional associations between these characteristics. Behavioural, psychological, cognitive and sleep difficulties are not well delineated and are likely associated with biopsychosocial factors. CHARGE syndrome (OMIM #214800) is a phenotypically complex genetic condition characterised by multi-system, multi-sensory impairments.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |